未登录

S

Stefan Schülke

Paul-Ehrlich-Institut

H指数:24

被引数:2,452

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Insights into Api m 10-Isoforms and Splice Variants: More Than One Major IgE-Binding Epitope

关于Api m 10-Isoforms和剪接变体的见解：存在多个主要的IgE结合表位

Clinical and Translational Allergy

IF4

2026-03-060

OAAI

Premastication—Review of an Infant Feeding Practice and Its Potential Impact on Allergy and Microbiome Development

食物预咀嚼——婴儿喂养实践及其对过敏和微生物群发育的潜在影响的综述

IF12

2025-09-080

OAAI

Brain organoids: building higher-order complexity and neural circuitry models

脑类器官：构建高阶复杂性和神经回路模型

Trends in Biotechnology

IF14.9

2025-04-120

OA

Establishment of an ELISA-based in vitro test system to quantify the major honey bee venom allergen Api m 10 in crude bee venoms and therapy allergen products

IF12

2024-09-120

OAAI

Effects of pectin methyl-esterification on intestinal microbiota and its immunomodulatory properties in naive mice

果胶甲酯化对幼鼠肠道菌群及其免疫调节特性的影响

CARBOHYDRATE POLYMERS

IF12.5

2024-06-014

OA

Novel adjuvants in allergen-specific immunotherapy: where do we stand?

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-02-239

OAAI

The Role of IgA in the Manifestation and Prevention of Allergic Immune Responses

CURRENT ALLERGY AND ASTHMA REPORTS

IF4.6

2023-08-2313

OAAI

β-1,3-glucan, but not β-1,3/1,6-glucan, exacerbates experimental food allergy, while both increase IgA induction

IF12

2023-08-115

OA

A flagellin-conjugate protein induces dual NLRC4-and NLRP3-inflammasome activation which modulates inflammatory cytokine secretion from macrophages

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-03-212

OAAI

Immune Metabolism in TH2 Responses: New Opportunities to Improve Allergy Treatment - Cell Type-Specific Findings (Part 2)

TH2反应中的免疫代谢: 改善过敏治疗的新机会-细胞类型特异性发现 (第二部分)

CURRENT ALLERGY AND ASTHMA REPORTS

IF4.6

2022-12-158

OAAI

Immune Metabolism in TH2 Responses: New Opportunities to Improve Allergy Treatment - Disease-Specific Findings (Part 1)

CURRENT ALLERGY AND ASTHMA REPORTS

IF4.6

2022-11-289

OAAI

Stimulation of naive B cells with a fusion protein consisting of FlaA and Bet v 1 induces regulatory B cells ex vivo

IF12

2022-10-2010

OA

Modulation of dendritic cell metabolism by an MPLA-adjuvanted allergen product for specific immunotherapy

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-08-173

OAAI

Immune Metabolism-An Opportunity to Better Understand Allergic Pathology and Improve Treatment of Allergic Diseases?

FRONTIERS IN ALLERGY

IF3.1

2022-03-099

OAAI

The Fusion Protein rFlaA:Betv1 Modulates DC Responses by a p38-MAPK and COX2-Dependent Secretion of PGE2 from Epithelial Cells

IF5.2

2021-12-049

OAAI

Immune Metabolism of IL-4-Activated B Cells and Th2 Cells in the Context of Allergic Diseases

FRONTIERS IN IMMUNOLOGY

IF5.9

2021-12-0125

OAAI

The Flagellin:Allergen Fusion Protein rFlaA:Betv1 Induces a MyD88-and MAPK-Dependent Activation of Glucose Metabolism in Macrophages

IF5.2

2021-10-0116

OAAI

Distinct single-component adjuvants steer human DC-mediated T-cell polarization via Toll-like receptor signaling toward a potent antiviral immune response

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2021-09-2419

OAAI

The Dietary Fiber Pectin: Health Benefits and Potential for the Treatment of Allergies by Modulation of Gut Microbiota

CURRENT ALLERGY AND ASTHMA REPORTS

IF4.6

2021-09-10101

OAAI

β-(1→4)-Mannobiose Acts as an Immunostimulatory Molecule in Murine Dendritic Cells by Binding the TLR4/MD-2 Complex

IF5.2

2021-07-1410

OAAI